DPT vaccine-induced lipoatrophy: an observational study

Area of Science:

• Pediatric Vaccinology
• Dermatology
• Immunology

Background:

• The Diphtheria Pertussis Tetanus (DPT) vaccine is a standard immunization for infants and children.
• While generally safe, known local reactions include erythema, induration, nodules, and abscesses.
• Injection site lipoatrophy is a previously unreported adverse reaction to DPT vaccination.

Purpose of the Study:

• To investigate the occurrence and characteristics of injection site lipoatrophy following DPT vaccination in infants.
• To identify potential risk factors and causative mechanisms for this rare adverse event.

Main Methods:

• A retrospective review of cases presenting with lipoatrophy at DPT injection sites was conducted between 2000-2005.
• The study included 8 infants from three hospitals in New Delhi, India.
• Patients underwent extensive evaluation to rule out other causes of lipoatrophy.

Main Results:

• Eight infants (2 male, 6 female), aged 4-12 months, developed lipoatrophy 4-8 weeks post-DPT vaccination.
• The vaccine was administered in the buttock in all cases, contrary to the recommended thigh injection site for infants.
• Most cases (6/8) occurred after the second DPT dose; no systemic causes were identified.

Conclusions:

• Diphtheria Pertussis Tetanus (DPT) vaccination can rarely lead to injection site lipoatrophy.
• Inadvertent subcutaneous administration into the buttock fat is a suspected causative factor.
• Educating healthcare providers on correct intramuscular vaccine administration techniques in infants is crucial to prevent this adverse reaction.